Publications by authors named "Ibis Soto"
Introduction: Neuromyelitis optica spectrum disorder (NMOSD) is a serious condition affecting people worldwide, including Latin America (LATAM). Healthcare disparities and economic limitations make effective treatment access challenging. It is crucial to consider the best practice therapeutic decision-making, including emerging long-term preventive therapies, to ensure patients in LATAM and elsewhere can effectively manage their disease all over the world.
View Article and Find Full Text PDFStatus of the neuromyelitis optica spectrum disorder in Latin America.
Mult Scler Relat Disord
August 2021
Article Synopsis
- Neuromyelitis optica spectrum disorders (NMOSD) present increasing diagnostic and treatment challenges in Latin America, with studies lacking comprehensive geographic outreach and demographic insights.
- A survey conducted by the Latin American Committee for Treatment and Research in MS gathered data from 62 experts across 21 countries, focusing on ethnic backgrounds, clinical characteristics, and diagnostic/therapeutic practices for NMOSD patients.
- The findings reveal that 2154 patients were reported, predominantly Mestizo (61.4%), with common symptoms including optic neuritis and transverse myelitis, and a high adherence (93.9%) to the 2015 International Panel for diagnosis.
Background: Neuromyelitis optica spectrum disorders (NMOSD), is a rare autoimmune inflammatory disease of the central nervous system. Since the countries of Latin America (LATAM) show contrast in geographic, social, environmental factors, and genetic heterogeneity, the information about NMOSD epidemiology in the region allows a better understanding of the disease and its clinical outcome.
Objectives: To determine the prevalence, relative frequency (RF), and clinical characteristics of NMOSD in a multiethnic Venezuelan cohort of patients with demyelinating disorders.